LASOBIO is expanding its industrial footprint in Morocco with the launch of a new production facility dedicated to dietary supplements, cosmetics and functional beverages. Backed by an investment of 100 million dirhams, the platform is designed to strengthen local manufacturing while supporting the company’s ambitions in international markets.
The new facility covers 2,500 square metres of technical space and has been developed according to pharmaceutical standards. It is equipped to manufacture products across seven dosage forms, with an annual production capacity of up to three million units per dosage form.
For LASOBIO, the investment represents more than an increase in production capacity. The company intends to gain greater control over the entire value chain, from sourcing and traceability of raw materials to manufacturing and quality control.
The facility brings together industrial expertise, advanced equipment and a selection of raw materials whose benefits are supported by clinical studies. International technology and industrial partnerships are also part of the platform’s operating model.
A key feature of the new site is its focus on Moroccan resources. LASOBIO has incorporated a botanical extraction process designed to develop the therapeutic potential of Moroccan plants while retaining more of the economic value generated by their industrial transformation within the country.
The facility also includes molecular transformation capabilities that allow certain active ingredients to be developed in dosage forms that have previously been less available in Morocco, including functional beverages and serums.
LASOBIO is positioning the site not only as a production centre for its own brands, but also as an industrial platform for other Moroccan entrepreneurs and professionals. Companies developing dietary supplements, cosmetics or functional beverages will be able to use the facility’s capabilities to develop their own projects and brands.
This model could give emerging businesses access to industrial infrastructure meeting demanding quality and traceability requirements without having to build their own manufacturing facilities.
The project is also expected to generate a significant employment impact. The facility will initially employ around 60 people directly. By 2030, LASOBIO expects the operation to support more than 150 direct jobs and close to 500 indirect positions across agriculture, logistics, distribution and related services.
The company says it will place particular emphasis on national skills, youth and women’s employment, as well as continuous training for its workforce.
The Moroccan facility is also intended to serve as a springboard for LASOBIO’s international expansion. Its German brand H3R LAB is expected to reach more than 1,000 points of sale in Germany from January 2027.
The company is simultaneously preparing to enter the UK market, with exports planned for 2027. Increasing production capacity in Morocco will support this expansion while allowing LASOBIO to develop partnerships with international players in dietary supplements, functional beverages and cosmetics.
The strategy reflects a broader ambition to establish Morocco as a competitive manufacturing base capable of serving both domestic and international markets.
LASOBIO, a subsidiary of the Promamec group, is also looking further ahead. The company aims to eventually develop a stronger presence in the pharmaceutical industry, potentially extending its current activities in supplements, cosmetics and functional products.
With the new facility, the group is seeking to combine local industrial capabilities, advanced manufacturing processes and international partnerships to build a Moroccan player capable of competing alongside established global companies in the health and wellness sector.
